• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡芦莫南的杀菌和溶菌活性及其对细菌形态的影响。

Bactericidal and bacteriolytic activities of carumonam and its effect on bacterial morphology.

作者信息

Nakao M, Kondo M, Imada A

出版信息

J Antimicrob Chemother. 1986 Apr;17(4):433-9. doi: 10.1093/jac/17.4.433.

DOI:10.1093/jac/17.4.433
PMID:3086273
Abstract

The in-vitro bactericidal and bacteriolytic activities and the effect on bacterial morphology of carumonam, a new N-sulfonated monocyclic beta-lactam antibiotic, against aerobic Gram-negative bacilli were compared with those of aztreonam. Both antibiotics, at their minimal inhibitory concentration (MIC) levels, were strongly bactericidal against species of Enterobacteriaceae, but weakly bactericidal against Pseudomonas aeruginosa. Their bactericidal activity was not increased by increasing the antibiotic concentration above the MICs. In contrast to this potent bactericidal activity, the bacteriolytic activity of carumonam and aztreonam was low and limited to enteric bacterial species like Escherichia coli. Filamentation was the major morphological change of Gram-negative bacilli after exposure to carumonam and aztreonam. E. coli and Serratia marcescens, but not P. aeruginosa, were converted to ghosts after prolonged incubation with carumonam.

摘要

将新型N-磺化单环β-内酰胺抗生素卡芦莫南对需氧革兰氏阴性杆菌的体外杀菌和溶菌活性以及对细菌形态的影响与氨曲南进行了比较。两种抗生素在其最低抑菌浓度(MIC)水平时,对肠杆菌科细菌均有强烈的杀菌作用,但对铜绿假单胞菌的杀菌作用较弱。将抗生素浓度增加至高于MIC水平时,其杀菌活性并未增强。与这种强大的杀菌活性相反,卡芦莫南和氨曲南的溶菌活性较低,且仅限于大肠杆菌等肠道细菌种类。丝状化是革兰氏阴性杆菌暴露于卡芦莫南和氨曲南后的主要形态变化。长时间与卡芦莫南孵育后,大肠杆菌和粘质沙雷氏菌会变成菌影,但铜绿假单胞菌不会。

相似文献

1
Bactericidal and bacteriolytic activities of carumonam and its effect on bacterial morphology.卡芦莫南的杀菌和溶菌活性及其对细菌形态的影响。
J Antimicrob Chemother. 1986 Apr;17(4):433-9. doi: 10.1093/jac/17.4.433.
2
Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic.新型磺化单环β-内酰胺抗生素卡芦莫南(Ro 17-2301,AMA-1080)的抗菌特性
Chemotherapy. 1985;31(6):440-50. doi: 10.1159/000238372.
3
The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.新型单环β-内酰胺类抗生素卡芦莫南(RO 17-2301,AMA-1080)的抗菌活性、β-内酰胺酶稳定性及纸片扩散法药敏试验
Am J Clin Pathol. 1986 Nov;86(5):608-18. doi: 10.1093/ajcp/86.5.608.
4
In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.新型N-磺化单环β-内酰胺抗生素卡芦莫南(AMA-1080)的体外和体内抗菌活性
Antimicrob Agents Chemother. 1985 May;27(5):821-7. doi: 10.1128/AAC.27.5.821.
5
Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.新型单环β-内酰胺类药物卡芦莫南的体外抗菌活性比较
Antimicrob Agents Chemother. 1986 Feb;29(2):346-9. doi: 10.1128/AAC.29.2.346.
6
In-vitro evaluation of carumonam (Ro 17-2301).卡芦莫南(Ro 17-2301)的体外评价
J Antimicrob Chemother. 1986 Sep;18(3):345-50. doi: 10.1093/jac/18.3.345.
7
The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.新型β-内酰胺类抗生素对124株革兰氏阴性杆菌的体外活性。
Pathology. 1985 Oct;17(4):636-9. doi: 10.3109/00313028509084767.
8
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates.卡芦莫南(RO 17-2301)、BMY-28142、氨曲南和头孢他啶对7620株连续临床分离细菌的体外活性。
Diagn Microbiol Infect Dis. 1986 Nov;5(4):345-9. doi: 10.1016/0732-8893(86)90041-6.
9
[Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].[铜绿假单胞菌对氨曲南与其他抗假单胞菌β-内酰胺类抗生素及庆大霉素的敏感性比较]
Arzneimittelforschung. 1985;35(8):1322-5.
10
In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.氨曲南对临床标本中革兰阴性菌的体外活性及其与其他常用抗生素的比较。
Methods Find Exp Clin Pharmacol. 1986 Apr;8(4):223-6.